PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 186 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $30,802,000 | -4.6% | 953,623 | +1.0% | 0.01% | 0.0% |
Q3 2016 | $32,301,000 | +5.9% | 943,934 | +4.4% | 0.01% | 0.0% |
Q2 2016 | $30,499,000 | -36.6% | 904,221 | -0.5% | 0.01% | -37.5% |
Q1 2016 | $48,140,000 | -30.6% | 908,647 | +0.7% | 0.01% | -27.3% |
Q4 2015 | $69,322,000 | +90.2% | 902,744 | +1.8% | 0.01% | +83.3% |
Q3 2015 | $36,453,000 | -41.3% | 886,946 | +1.0% | 0.01% | -40.0% |
Q2 2015 | $62,112,000 | -34.4% | 878,284 | -17.5% | 0.01% | -33.3% |
Q1 2015 | $94,622,000 | +15.0% | 1,064,965 | +14.8% | 0.02% | +15.4% |
Q4 2014 | $82,270,000 | -9.1% | 927,926 | -0.7% | 0.01% | -13.3% |
Q3 2014 | $90,542,000 | +0.7% | 934,188 | -4.5% | 0.02% | 0.0% |
Q2 2014 | $89,872,000 | +43.1% | 978,358 | +9.0% | 0.02% | +36.4% |
Q1 2014 | $62,821,000 | +26.2% | 897,564 | +3.6% | 0.01% | +22.2% |
Q4 2013 | $49,792,000 | +134.9% | 866,093 | +96.5% | 0.01% | +125.0% |
Q3 2013 | $21,193,000 | +93.5% | 440,827 | +16.7% | 0.00% | +100.0% |
Q2 2013 | $10,952,000 | – | 377,641 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |